Patient-Reported Outcomes (pros) from the Phase 2 TRANSCEND FL Study of Lisocabtagene Maraleucel (Liso-Cel) in Patients (pts) with Relapsed or Refractory Follicular Lymphoma (FL)
Blood（2023）
Key words
T Cell Therapy,CAR T Cells,Tumor Regression,Adoptive Cell Transfer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined